Tae Dong Han

This inventor holds 13 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Yuhan Corporation, Dong-A Pharmaceutical Co., Ltd. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tae Dong Han. Retrieved from https://idiyas.com/inventor/tae-dong-han

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 2)

% Patents Active = 76.9

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 11.6

ph-index = 4

Forward Citations = 35(Granted Patents)

Location History:

Uiwang, KR (2008)
Yongin-si, KR (2020 - 2023)
Gyeonggi-do, KR (2022 - 2024)

Company Filing History:

Dong-A Pharmaceutical Co., Ltd

patents

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

Aminopyridine Derivative

Triazolone Compounds

Pharmaceutical Compositions

Triazolopyridin-3-ones

Crystalline Form

3,3-Difluoroallylamines

Salt Compounds

Aryl Derivatives

Heteroaryl Derivatives

Phenylpiperidin Derivatives

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12428401 - Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same (2025-09-30),

2. 11981659 - Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same (2024-05-14),

3. 11820769 - Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same (2023-11-21),

4. 11780830 - Triazolone derivatives or salts thereof and pharmaceutical compositions comprising the same (2023-10-10),

5. 11713308 - 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same (2023-08-01),

6. 11492335 - Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the same (2022-11-08),

7. 11453656 - Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same (2022-09-27),

8. 11168073 - 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same (2021-11-09),

9. 11091479 - Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same (2021-08-17),

10. 10995086 - Triazolone derivatives or salts thereof and pharmaceutical compositions comprising the same (2021-05-04),

11. 10899719 - Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the same (2021-01-26),

12. 10562865 - Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the same (2020-02-18),

13. 7342027 - 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof (2008-03-11),

Title: Innovations of Tae Dong Han

Introduction

Tae Dong Han is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, holding a total of 13 patents. His work focuses on developing novel compounds that enhance drug stability and bioavailability.

Latest Patents

One of his latest patents involves the salt of an aminopyridine derivative compound, specifically a mesylate salt of N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidine-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide. This invention presents a novel crystalline form that demonstrates excellent stability, solubility, and bioavailability when administered alone or in combination with other drugs. The high purity of this compound further enhances its potential for pharmaceutical applications.

Career Highlights

Throughout his career, Tae Dong Han has worked with notable companies in the pharmaceutical industry, including Yuhan Corporation and Dong-a Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Tae Dong Han has collaborated with several professionals in his field, including Hee Jae Tak and Eun Kyung Kim. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Tae Dong Han's contributions to pharmaceutical innovations are noteworthy, particularly in the development of compounds that improve drug efficacy. His work continues to impact the industry positively, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.